May IgG4-related disease be reactivated by SARS-CoV-2 infection?
| dc.authorid | Şenol Kobak / 0000-0001-8270-640X | en_US |
| dc.authorscopusid | Şenol Kobak / 12782228700 | |
| dc.authorwosid | Şenol Kobak / AAO-2482-2020 | en_US |
| dc.contributor.author | Kobak, Şenol | |
| dc.date.accessioned | 2022-07-06T14:01:43Z | |
| dc.date.available | 2022-07-06T14:01:43Z | |
| dc.date.issued | 2022 | en_US |
| dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| dc.description.abstract | No Abstract Available | en_US |
| dc.identifier.citation | Kobak S. May IgG4-related disease be reactivated by SARS-CoV-2 infection? Reumatologia. 2022;60(2):161-162. doi: 10.5114/reum.2022.115985. Epub 2022 May 18. PMID: 35782033; PMCID: PMC9238317. | en_US |
| dc.identifier.doi | 10.5114/reum.2022.115985 | en_US |
| dc.identifier.endpage | 162 | en_US |
| dc.identifier.issn | 2084-9834 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.pmid | 35782033 | en_US |
| dc.identifier.scopus | 2-s2.0-85131177453 | en_US |
| dc.identifier.scopusquality | Q3 | en_US |
| dc.identifier.startpage | 161 | en_US |
| dc.identifier.uri | http://doi.org/10.5114/reum.2022.115985 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12713/2988 | |
| dc.identifier.volume | 60 | en_US |
| dc.identifier.wos | WOS:000800392400012 | en_US |
| dc.identifier.wosquality | N/A | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.indekslendigikaynak | Scopus | en_US |
| dc.indekslendigikaynak | PubMed | en_US |
| dc.institutionauthor | Kobak, Şenol | |
| dc.language.iso | en | en_US |
| dc.publisher | TerMedia | en_US |
| dc.relation.ispartof | Reumatologia | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | May IgG4-related disease be reactivated by SARS-CoV-2 infection? | en_US |
| dc.type | Editorial | en_US |
